CURAXIS PHARMACEUTICAL CORP Deferred Revenue
CURAXIS PHARMACEUTICAL CORP had Deferred Revenue of $1.73 million as of 2012-03-31, per its 10-Q filed 2012-05-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2012-05-14
- 2012-03-31: Deferred Revenue $1.73M.
- 2011-12-31: Deferred Revenue $1.73M.
- 2011-09-30: Deferred Revenue $1.73M.
- 2011-06-30: Deferred Revenue $1.73M.
| Period end | Deferred Revenue |
|---|---|
| 2012-03-31 | $1.73M 10-Q · filed 2012-05-14 |
| 2011-12-31 | $1.73M 10-Q · filed 2012-05-14 |
| 2011-09-30 | $1.73M 10-Q · filed 2011-11-10 |
| 2011-06-30 | $1.73M 10-Q · filed 2011-08-12 |
| 2010-12-31 | $1.73M 10-K · filed 2012-03-29 |